Affimed N.V. (AFMD) was a big mover last session, as its shares rose over 15% on the day. This led to more shares changing hands than in a normal session. Yesterday’s rally continues the uptrend for the company since Mar 27, as the stock is now up above 35%.
Over the last 30 days, the company witnessed two estimate revisions and the Zacks Consensus Estimate also moved higher, suggesting more solid ahead. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.
Affimed currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.
Another favorably-ranked stock in the med-drugs industry is Flamel Technologies SA (FLML) with a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment